to elucidate the origin of the fibrin/fibrinogen degradation products ( f.d.p . ) occurring in the urine in glomerulonephritis 28 patients with glomerulonephritis were examined for renal fibrinolytic activity , f.d.p . in urine and serum , and blood fibrinolytic activators and blood fibrinolytic activators and inhibitors .
C0017658
glomerulonephritis
C0022646
renal